Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies.
Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies.
复制标题
描述患者报告的跛行治疗目标,以支持以患者为中心的治疗选择和测量策略。
DOI:
10.1016/j.jvs.2022.09.002
复制
发表时间:
2022
影响因子:
4.3
通讯作者:
Corriere,MatthewA
中科院分区:
文献类型:
--
作者:
Powell,ChloéA;Kim,GloriaY;Edwards,SydneyN;Aalami,Oliver;Treat-Jacobson,Diane;Byrnes,MaryE;Osborne,NicholasH;Corriere,MatthewA
ObjectivePatient-reported outcomes (PRO) have been increasingly emphasized for peripheral artery disease (PAD). Patient-defined treatment goals and expectations, however, are poorly understood and might not be achievable or aligned with guidelines or clinical outcomes. We evaluated the patient-reported treatment goals among patients with claudication and the associations between patient characteristics, goals, and PAD-specific PRO scores.MethodsPatients with a diagnosis of claudication were prospectively recruited. Patient-defined treatment goals and outcomes related to walking distance, duration, and speed were quantified using multiple-choice survey items. Free-text items were used to identify activities other than walking distance, duration, or speed associated with symptoms and treatment goals. The peripheral artery disease quality of life and walking impairment questionnaire instruments were included as PRO. The treatment goal categories were compared with the PRO percentile scores using 95% confidence intervals (CIs), categorical tests, and logistic regression models. Associations between the patient characteristics and PRO were evaluated using linear and ordinal logistic regression models.ResultsA total of 150 patients meeting the inclusion criteria were included in the present study. Of these 150 patients, 144 (96%) viewed the entire survey. Their mean age was 70.0 ± 11.3 years, and 32.9% were women. Most of the respondents had self-reported their race as White (n = 135), followed by Black (n = 3), Asian (n = 2), Native American (n = 2), and other/unknown (n = 2). Two participants self-reported Hispanic ethnicity. The primary treatment goals were an increased walking distance or duration without stopping (62.0%), the ability to perform a specific activity or task (23.0%), an increased walking speed (8.0%), or other/none of the above (7.0%). The specific activities associated with symptoms or goals included outdoor recreation (38.5%), labor-related tasks (30.7%), sports (26.9%), climbing stairs (23.1%), uphill walking (19.2%), and shopping (6%). Among the patients choosing an increased walking distance and duration as the primary goals, 64% had indicated that a distance of ≥0.5 mile (2640 ft) and 59% had indicated a duration of ≥30 minutes would be a minimum increase consistent with meaningful improvement. Increasing age was associated with lower odds of a distance improvement goal of ≥0.5 mile (odds ratio [OR], 0.68 per 5 years; 95% CI, 0.51-0.92;P= .012) or duration improvement goal of ≥30 minutes (OR, 0.76 per 5 years; 95% CI, 0.58-0.99;P= .047). Patient characteristics associated with PAD Quality of Life percentile scores included age, ankle brachial index, and gender. Ankle brachial index was the only patient characteristic associated with the walking impairment questionnaire percentile scores.ConclusionsPatients define treatment goals according to their desired activities and expectations, which may influence their goals and perceived outcomes. Patients’ expectations of minimum increases in walking distance and duration consistent with meaningful improvement exceeded reported minimum important difference criteria for many patients and would not be captured using common clinic-based walking tests. Patient age was associated with both treatment goals and PRO scores, and the related floor and ceiling effects could influence sensitivity to PRO changes for younger and older patients, respectively. Heterogeneity in treatment goals supports consideration of tailored decision-making and outcomes informed by patient characteristics and perspectives.
登录
查看更多内容
DOI:
--
发表时间:
--
期刊:
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.3
作者:
McDermott, MM;Liu, KA;Greenland, P
通讯作者:
Greenland, P
DOI:
--
发表时间:
2021
期刊:
Circulation. Cardiovascular Interventions
影响因子:
--
作者:
Jennifer A. Rymer;Dennis I. Narcisse;Michael Cosiano;John Tanaka;Mary M. McDermott;Diane Treat;Michael S. Conte;Brandi Tuttle;Manesh R. Patel;K. Smolderen
通讯作者:
K. Smolderen
DOI:
10.1024/0301-1526.28.1.25
发表时间:
1999
期刊:
VASA. Zeitschrift fur Gefasskrankheiten
影响因子:
--
作者:
U. Müller;I. Kirchberger;A. Wiesemann
通讯作者:
A. Wiesemann
影响因子:
4.5
作者:
Harris PA;Taylor R;Thielke R;Payne J;Gonzalez N;Conde JG
通讯作者:
Conde JG